Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Back to dashboard
Company Information
About this company
Key people
Stanislas Veillet
Chairman of the Board of Directors
Nicolas Fellmann
Chief Financial Officer
Jean Mariani
Director
Claude Allary
Independent Director
Nadine Coulm
Independent Director
Click to see more
Key facts
- Shares in issue23.43m
- EPICALBPS
- ISINFR001400OLP5
- LocationFrance
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap€14.40m
- Employees18
- ExchangeEuronext Paris
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.